Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

  • Archangels leads further investment in home-grown Scottish innovators

    Archangels has led investment of £6.2 million in Scottish early stage companies in the first quarter of 2020 Four tech and life sciences businesses – Blackford Analysis; Fios Genomics; Optoscribe; and Speech Graphics – were the recipients of the additional investment. £2.6 million came from Archangels members, with £1 million from Scottish Investment Bank, the […]

  • Holyrood Must Keep the Most Promising Scots Tech Firms Afloat

    Holyrood urged to fill funding gap for early-stage tech firms with bespoke loans The Scottish government has been urged to do more to protect Scotland’s early- stage tech industry amid increasing concerns the sector is falling between the cracks of government support schemes. David Ovens, Managing Director of Archangels, Scotland’s largest business angel investment syndicate, […]

  • Scottish Enterprise Coronavirus Advice for Businesses in Scotland

    Scottish Enterprise has gathered together a list of websites that give useful information on business continuity for employers and businesses. These sites can help you prepare and manage your business during this time: Go to the Find Business Support website for the latest information and advice on help and finance available You can download our checklist (Word document, 33KB) […]

  • New Optoscribe Funding will Support Continued Expansion

    Optoscribe has announced completion of a new investment round lead by Archangels with Co-investment from SIB, Maven & Par Equity Livingston, UK | 12 March 2020 Optoscribe Ltd, a world-leading supplier of 3D glass-based integrated photonics components, has announced that the company has closed its latest investment round. This funding round, which was led by […]

  • CALCiViS receives Approvable Letter for its unique CALCiViS® Imaging System from US FDA

    CALCiViS System, developed to enable and drive the adoption of preventive dentistry – enables real-time visualisation of active tooth decay Edinburgh | 04 March 2020 CALCiViS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announces receipt of an Approvable Letter for the Premarket Approval (PMA) of its […]

  • Fios Announces Strategic Partnership with Charles River

    Strategic Partnership Seen as a Game-changer For Edinburgh-based Fios Genomics Edinburgh | January 2020 Archangels’ investee company, Fios Genomics (“Fios”), which helps pharmaceutical and biotech companies to analyse the large amounts of data generated during drug development, has announced a strategic partnership with one of the world’s largest contract research organisations, Charles River Laboratories, (“Charles […]

Company portfolio

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.